Patent · US Active

Anticancer agent

US8507443B2 · kind B2 · utility

5Cited by

0References

10Claims

0Family size

Assignee

The Research Foundation For Microbial Diseases of Osaka University · JP

Inventors

Eisuke Mekada · Suita, JP
Shingo Miyamoto · Tokyo, JP

Key dates

Filing date	Aug 19, 2005
Grant date	Aug 13, 2013
Priority date	—
Expiry date	Feb 7, 2029

Classification

Technology area (CPC G)Physics
CPC primaryG08G1/015
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is an antineoplastic agent characterized by including at least one of taxol and taxol derivatives and a protein which is a mutant of diphtheria toxin, having an activity to inhibit a binding between HB-EGF and EGFR and substantially not having a toxicity of diphtheria toxin as active ingredients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.